MedTrace Logo

A Cohort Study on Screening and Follow-up of High-risk Population of PDAC Based on EUS

NCT05621824 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 900

Last updated 2024-04-09

No results posted yet for this study

Summary

Study objective: The purpose of this study is to establish a prospective follow-up cohort of high-risk groups of pancreatic cancer, screen early pancreatic cancer through EUS and other means according to the existing clinical process, and evaluate each risk factors. And to prospectively collect biological samples to find molecular markers for early diagnosis of pancreatic cancer.

Study design: This is a real world, multicenter, prospective, observational cohort study.

Conditions

  • Carcinoma, Pancreatic Ductal

Interventions

DEVICE

Endoscopic ultrasound

Use endoscopic ultrasound to examine the pancreatic lesions.

PROCEDURE

EUS-Fine needle aspiration

If solid mass of pancreas was found during EUS, EUS-FNA shall be conducted for diagnosis.

Sponsors & Collaborators

  • Beijing Hospital

    collaborator OTHER_GOV

  • Tongji Hospital

    collaborator OTHER

  • The First Affiliated Hospital of Xiamen University

    collaborator OTHER

  • Peking Union Medical College Hospital

    lead OTHER

Principal Investigators

  • Xi Wu, M.D. · Peking Union Medical College Hospital

  • Shengyu Zhang, M.D. · Peking Union Medical College Hospital

  • Yuheng Zhang, MD candidate · Peking Union Medical College Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-31
Primary Completion
2026-06-30
Completion
2028-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05621824 on ClinicalTrials.gov